No profile data available.
Sunil Healthcare Limited (SUNLOC.BO) is a healthcare company in the drug manufacturing contractors industry, based in New Delhi, India, with about 158 full-time employees.
It reported revenue of 833.78 million INR for fiscal year 2025, down 7.5% from fiscal year 2024, and net income of -14.17 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 218.37 million INR, up 6.7% from a year before. Its market capitalization was 743.47 million INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Sunil Healthcare Limited engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally. It offers EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, gelatin, HPMC/vegetable, and pullulan capsules.
Sunil Healthcare reported 833.78 million INR in revenue for fiscal year 2025, down 7.5% from 901.59 million INR in fiscal year 2024. In Q3 2026 revenue was 218.37 million INR.
743.47 million INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Makers Laboratories Limited (MAKERSL.BO), Panchsheel Organics Limited (PANCHSHEEL.BO), Tyche Industries Limited (TYCHE.BO), Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS).